Vincerx Pharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Vincerx Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q3 2024.
- Vincerx Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$7.84M, a 12.9% increase year-over-year.
- Vincerx Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$27M, a 41.8% increase year-over-year.
- Vincerx Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$40.2M, a 36.2% increase from 2022.
- Vincerx Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63M, a 60.2% decline from 2021.
- Vincerx Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$39.3M, a 136% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)